Issued Patents 2019
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10494382 | Crystalline solvate comprising 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile, methanol, N-N-dimethylformamide, and water | Xiaojun Huang | 2019-12-03 |
| 10493077 | Fused imidazo-piperidine JAK inhibitor compound | Paul R. Fatheree, Lan Jiang, Marta Dabros, Jerry Nzerem | 2019-12-03 |
| 10472335 | Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof | Adam D. Hughes, Melissa Fleury, Miroslav Rapta, R. Michael Baldwin, David L. Bourdet | 2019-11-12 |
| 10392368 | Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors | Erik Fenster, Tom M. Lam, Mandy Loo, Robert Murray McKinnell, Anthony Francesco Palermo +5 more | 2019-08-27 |
| 10369142 | Combination dosage form of a mu opioid receptor antagonist and an opioid agent | Shaoling Li, Manshiu Leung, Hao Zhang, Yun Mo | 2019-08-06 |
| 10251874 | Crystalline forms of a JAK inhibitor compound | Marta Dabros, Jerry Nzerem, Melanie A. Kleinschek, Glenn D. Crater | 2019-04-09 |
| 10183942 | JAK kinase inhibitor compounds for treatment of respiratory disease | Noah Benjamin, Marta Dabros | 2019-01-22 |
| 10172834 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Melissa Fleury, Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Miroslav Rapta | 2019-01-08 |